Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 AUD | 0.00% | -33.33% | -95.00% |
16/04 | Melodiol Global's Revenue Surges 79% in Q1 | MT |
09/04 | Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia Pacific
38.8
%
| 0 | 0.0 % | 7 | 38.8 % | - |
Canada
36.7
%
| 4 | 50.5 % | 7 | 36.7 % | +58.00% |
Europe
24.5
%
| 2 | 21.2 % | 5 | 24.5 % | +151.14% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia Pacific
38.8
%
| 0 | 0.0 % | 7 | 38.8 % | - |
Canada
36.7
%
| 4 | 50.5 % | 7 | 36.7 % | +58.00% |
Europe
24.5
%
| 2 | 21.2 % | 5 | 24.5 % | +151.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Lay
CEO | Chief Executive Officer | - | 17/21/17 |
John Griese
COO | Chief Operating Officer | 38 | 14/18/14 |
Gian Trepp
SAM | Sales & Marketing | - | - |
Winton Willesee
SEC | Corporate Secretary | 54 | 19/18/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Linton
BRD | Director/Board Member | 57 | 17/22/17 |
Peter Hatfull
BRD | Director/Board Member | 71 | 30/22/30 |
Boaz Wachtel
FOU | Founder | - | 20/15/20 |
William Lay
CEO | Chief Executive Officer | - | 17/21/17 |
Micheline McKay
BRD | Director/Board Member | - | 17/22/17 |
Ben Quirin
BRD | Director/Board Member | - | 10/22/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 237,116,368 | 168,382,258 ( 71.01 %) | 0 | 71.01 % |
Company contact information
Melodiol Global Health Ltd.
145 Stirling Highway Suite 5 CPC
6009, Nedlends
+61 8 9389 3180
http://www.cresopharma.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-95.00% | 891K | |
+31.26% | 662B | |
+21.96% | 546B | |
-5.31% | 359B | |
+16.92% | 323B | |
+4.68% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.21% | 167B |
- Stock Market
- Equities
- ME1 Stock
- Company Melodiol Global Health Limited